Deficiency of intestinal immunity with graft-vs.-host disease in humans

The Journal of Infectious Diseases
W E BeschornerG W Santos

Abstract

A possible deficiency of secretory immunity was investigated in 55 bone marrow recipients and nine control patients by evaluation of lamina propria plasma cells, Peyer's patch and mesenteric lymph node cellularity, and mucosal injury. All short-term survivors had marked depletion of Peyer's patch and mesenteric lymph node cellularity; long-term survivors demonstrated repopulation. In autologous or syngeneic marrow recipients and patients without engraftment, the intestines contained numerous IgA-bearing, IgM-bearing, and total plasma cells, compared with a marked decrease in these cells in patients with allogeneic engraftment. Patients with graft-vs.-host disease (GVHD) had even fewer IgA-bearing plasma cells and much greater mucosal injury. These results suggest that with allogeneic engraftment and GVHD, host intestinal plasma cells are depleted before repopulation and maturation of Peyer's patches and mesenteric lymph nodes with donor cells. These patients, therefore, are at increased risk for infection by intestinal organisms.

Citations

Aug 10, 1992·Journal of Immunological Methods·C Cunningham-RundlesJ Keenan
Apr 1, 1991·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A BraunerI Kühn
Oct 1, 1991·Journal of Clinical Pathology·R L BryanD W Milligan
May 1, 1986·The Journal of Clinical Investigation·D Guy-Grand, P Vassalli
Apr 1, 1990·The Journal of Surgical Research·L R SchererP M Colombani
Oct 23, 1987·The American Journal of Medicine·K M Sullivan
Aug 1, 1987·The American Journal of the Medical Sciences·P J Tutschka
Feb 1, 1982·Clinical Immunology and Immunopathology·W E BeschornerG W Santos
Jan 1, 1986·International Journal of Cell Cloning·K M Sullivan
Feb 1, 1993·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·V M Herrmann, P J Petruska
Feb 1, 1995·Journal of Clinical Pathology·C FeganJ A Whittaker
Jan 1, 1990·Springer Seminars in Immunopathology·G J Cox, G B McDonald
Jan 1, 1987·Transactions of the Royal Society of Tropical Medicine and Hygiene·I N Ross, T Abraham
Feb 1, 1987·Journal of Dental Research·K T IzutsuD E Johnson
Aug 1, 1987·Infection Control : IC·C L WellsF S Rhame

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.